Operating Profit Margin
since 2005
Calculation
Biogen Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Income from operations1 | ÷ | Revenues1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 25.87% | = | 100 | × | 2,840,700) | ÷ | 10,981,700) |
| Dec 31, 2020 | 33.84% | = | 100 | × | 4,550,100) | ÷ | 13,444,600) |
| Dec 31, 2019 | 48.98% | = | 100 | × | 7,042,600) | ÷ | 14,377,900) |
| Dec 31, 2018 | 43.77% | = | 100 | × | 5,888,600) | ÷ | 13,452,900) |
| Dec 31, 2017 | 43.54% | = | 100 | × | 5,344,200) | ÷ | 12,273,900) |
| Dec 31, 2016 | 44.99% | = | 100 | × | 5,150,400) | ÷ | 11,448,800) |
| Dec 31, 2015 | 45.44% | = | 100 | × | 4,891,000) | ÷ | 10,763,800) |
| Dec 31, 2014 | 40.94% | = | 100 | × | 3,972,414) | ÷ | 9,703,324) |
| Dec 31, 2013 | 36.29% | = | 100 | × | 2,515,509) | ÷ | 6,932,199) |
| Dec 31, 2012 | 33.64% | = | 100 | × | 1,855,849) | ÷ | 5,516,461) |
| Dec 31, 2011 | 34.16% | = | 100 | × | 1,724,691) | ÷ | 5,048,634) |
| Dec 31, 2010 | 26.48% | = | 100 | × | 1,248,889) | ÷ | 4,716,423) |
| Dec 31, 2009 | 29.59% | = | 100 | × | 1,295,427) | ÷ | 4,377,348) |
| Dec 31, 2008 | 29.62% | = | 100 | × | 1,213,611) | ÷ | 4,097,507) |
| Dec 31, 2007 | 24.59% | = | 100 | × | 779,772) | ÷ | 3,171,617) |
| Dec 31, 2006 | 16.40% | = | 100 | × | 440,020) | ÷ | 2,683,049) |
| Dec 31, 2005 | 9.74% | = | 100 | × | 236,040) | ÷ | 2,422,500) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The operational performance from 2005 to 2021 is characterized by a prolonged period of margin expansion and peak profitability, followed by a significant contraction in the final two years of the period.
- Operational Margin Expansion (2005–2014)
- A consistent upward trend in profitability is observed during this interval. The operating profit margin grew from 9.74% in 2005 to 40.94% in 2014. This growth was driven by a rapid increase in income from operations, which rose from $236.04 million to $3.97 billion, significantly outpacing the growth in total revenues.
- Peak Profitability and Stabilization (2015–2019)
- Operational efficiency remained high and relatively stable between 2015 and 2019, with margins consistently exceeding 43%. The peak operating profit margin of 48.98% was reached in 2019, the same year the entity achieved its highest recorded revenue of $14.38 billion and highest income from operations of $7.04 billion.
- Profitability Contraction (2020–2021)
- A sharp decline in operational performance occurred after 2019. The operating profit margin dropped to 33.84% in 2020 and further declined to 25.87% by 2021. This downturn is associated with a simultaneous decrease in total revenues and a substantial reduction in income from operations, which fell to $2.84 billion by the end of 2021.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
How can I help you?
Comparison to Competitors
Biogen Inc., operating profit margin, long-term trends, comparison to competitors
| Biogen Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 25.87% | 31.89% | 31.44% | 25.35% | 36.72% | 55.67% | 25.57% | 36.73% |
| Dec 31, 2020 | 33.84% | 24.81% | 37.70% | 18.99% | 16.72% | 42.09% | 24.19% | 46.03% |
| Dec 31, 2019 | 48.98% | 39.03% | 43.57% | 18.25% | 19.38% | 28.10% | 17.99% | 28.77% |
| Dec 31, 2018 | 43.77% | 19.49% | 45.55% | 17.11% | 37.83% | 37.77% | 15.53% | 20.84% |
| Dec 31, 2017 | 43.54% | 33.99% | 45.76% | 16.48% | 55.04% | 35.41% | 14.19% | 4.95% |
| Dec 31, 2016 | 44.99% | 36.60% | 44.74% | 16.29% | 58.87% | 27.38% | 13.40% | 0.58% |
| Dec 31, 2015 | 45.44% | 32.97% | 40.44% | 16.87% | 69.03% | 30.51% | 13.77% | -45.23% |
| Dec 31, 2014 | 40.94% | 17.09% | 32.03% | 17.23% | 62.37% | 29.74% | 14.82% | -119.30% |
| Dec 31, 2013 | 36.29% | 30.14% | 32.25% | 17.13% | 41.87% | 36.11% | 12.30% | -74.54% |
| Dec 31, 2012 | 33.64% | 31.65% | 33.52% | 17.33% | 42.67% | 33.20% | 11.85% | 0.15% |
| Dec 31, 2011 | 34.16% | — | 28.19% | 16.27% | 46.77% | -46.02% | 10.62% | 8.07% |
| Dec 31, 2010 | 26.48% | — | 37.82% | 16.41% | 53.62% | -21.23% | 11.72% | -485.51% |
| Dec 31, 2009 | 29.59% | — | 38.37% | 13.79% | 54.55% | -19.54% | 10.38% | -602.63% |
| Dec 31, 2008 | 29.62% | — | 35.50% | 14.72% | 52.68% | -37.67% | 11.71% | -263.65% |
| Dec 31, 2007 | 24.59% | — | 27.81% | 15.79% | 57.98% | -91.55% | 10.00% | -210.94% |
| Dec 31, 2006 | 16.40% | — | 27.71% | 15.82% | -29.32% | -169.68% | 6.38% | -105.86% |
| Dec 31, 2005 | 9.74% | — | 40.33% | 15.84% | 61.41% | -187.97% | 10.01% | -93.15% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).